Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov;51(6):815-9.

Duration of action of sustained-release buprenorphine in 2 strains of mice

Affiliations

Duration of action of sustained-release buprenorphine in 2 strains of mice

Elizabeth T Carbone et al. J Am Assoc Lab Anim Sci. 2012 Nov.

Abstract

Buprenorphine HCl is a common analgesic for laboratory mice undergoing surgical procedures. The documented duration of action of buprenorphine HCl is as short as 3 to 5 h in mice, potentially necessitating readministration for continued analgesia. A long-acting buprenorphine formulation would reduce handling-associated stress and provide uninterrupted analgesia. This study used the hot-plate assay to assess the antinociceptive effects of a single injection of sustained-release buprenorphine (bup-SR), buprenorphine-HCl (bup-HCl), and saline over 72 h in young adult male BALB/cJ and SWR/J mice. SWR/J mice had shorter baseline latencies than did BALB/cJ mice, possibly reflecting greater sensitivity to thermal nociception. Relative increase from baseline latency (% maximal possible effect) was significant for buprenorphine-SR at 2, 6, and 12 h compared with saline. According to results from a hot-plate assay, the analgesic efficacy of buprenorphine-SR appears to last at least 12 h in male BALB/cJ and SWR/J mice.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Hot-plate apparatus and endpoint behavior. Two observers were present during data collection, and a digital camera and mirror were set up to allow subsequent review of video recordings. This mouse is licking his hind paw, a nocifensive behavior.
Figure 2.
Figure 2.
Percentage of maximal possible effect (%MPE; mean ± SEM, n = 15) for each treatment group at each time point. Significant differences were present at 2 (sustained-release buprenorphine [bup-SR] > buprenorphine-HCl [bup-HCl]; bup-SR > saline), 6 (bup-SR > saline), 12 (bup-SR > saline), and 72 (bup-SR > bup-HCl) h. *, Significant (P < 0.05) difference between bracketed values.

References

    1. Bannon AW, Malmberg AB.2007. Models of nociception: hot-plate, tail-flick, and formalin tests in rodents. Curr Protoc Neurosci Chapter 8:Unit 8.9. - PubMed
    1. Belknap JK, Lame M, Danielson PW. 1990. Inbred strain differences in morphine-induced analgesia with the hot-plate assay: a reassessment. Behav Genet 20:333–338 - PubMed
    1. Catbagan DL, Quimby JM, Mama KR, Rychel JK, Mich PM. 2011. Comparison of the efficacy and adverse effects of sustained-release buprenorphine hydrochloride following subcutaneous administration and buprenorphine hydrochloride following oral transmucosal administration in cats undergoing ovariohysterectomy. Am J Vet Res 72:461–466 - PubMed
    1. Christoph T, Kogel B, Schiene K, Meen M, De Vry J, Friderichs E. 2005. Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain. Eur J Pharmacol 507:87–98 - PubMed
    1. Cowan A, Lewis JW, Macfarlane IR. 1977. Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. Br J Pharmacol 60:537–545 - PMC - PubMed

Publication types